California State Teachers Retirement System lessened its holdings in shares of Mylan (NASDAQ:MYL) by 7.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 931,871 shares of the company’s stock after selling 79,810 shares during the period. California State Teachers Retirement System owned about 0.17% of Mylan worth $29,233,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in MYL. Meeder Asset Management Inc. raised its stake in shares of Mylan by 76.9% during the third quarter. Meeder Asset Management Inc. now owns 3,393 shares of the company’s stock valued at $106,000 after acquiring an additional 1,475 shares in the last quarter. BT Investment Management Ltd bought a new stake in shares of Mylan during the third quarter valued at approximately $142,000. Global X Management Co. LLC raised its stake in shares of Mylan by 59.2% during the second quarter. Global X Management Co. LLC now owns 4,801 shares of the company’s stock valued at $186,000 after acquiring an additional 1,786 shares in the last quarter. Doliver Capital Advisors LP bought a new stake in shares of Mylan during the second quarter valued at approximately $201,000. Finally, Sheaff Brock Investment Advisors LLC bought a new stake in shares of Mylan during the second quarter valued at approximately $210,000. Institutional investors and hedge funds own 75.04% of the company’s stock.

Several analysts have recently weighed in on MYL shares. Wells Fargo & Company set a $32.00 price target on shares of Mylan and gave the company a “hold” rating in a research note on Wednesday, October 4th. Morgan Stanley lifted their price target on shares of Mylan from $36.00 to $39.00 and gave the company an “equal weight” rating in a research note on Friday, October 6th. BidaskClub raised shares of Mylan from a “hold” rating to a “buy” rating in a research note on Friday, October 27th. BMO Capital Markets reissued a “buy” rating and issued a $45.00 price objective on shares of Mylan in a research note on Friday, September 29th. Finally, ValuEngine raised shares of Mylan from a “hold” rating to a “buy” rating in a research note on Monday, October 2nd. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and fourteen have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $42.41.

Mylan (MYL) opened at $40.52 on Friday. The company has a market cap of $21,462.81, a P/E ratio of 8.51, a P/E/G ratio of 2.19 and a beta of 1.38. Mylan has a 12 month low of $29.39 and a 12 month high of $45.87. The company has a quick ratio of 0.95, a current ratio of 1.46 and a debt-to-equity ratio of 1.05.

Mylan (NASDAQ:MYL) last issued its quarterly earnings results on Monday, November 6th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.20 by ($0.10). The business had revenue of $2.99 billion for the quarter, compared to analyst estimates of $3.09 billion. Mylan had a return on equity of 20.63% and a net margin of 7.28%. The business’s revenue for the quarter was down 2.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.38 earnings per share. analysts forecast that Mylan will post 4.56 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this piece can be viewed at https://www.watchlistnews.com/mylan-myl-holdings-lessened-by-california-state-teachers-retirement-system/1769019.html.

About Mylan

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan (NASDAQ:MYL).

Institutional Ownership by Quarter for Mylan (NASDAQ:MYL)

Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.